STING1 Gene: Structure, Function, and Clinical Significance

Comprehensive guide to STING1 (TMEM173) – the innate immune sensor of cytosolic DNA, its role in STING-associated vasculopathy, cancer immunity, and therapeutic targeting.

Gene Information Card

Symbol STING1
Full Name Stimulator of Interferon Response cGAMP Interactor 1
Gene Type Protein coding
Chromosomal Location 5q31.2
NCBI Gene ID 340061 ncbi.nlm.nih.gov/gene/340061
Ensembl ID ENSG00000184584
UniProt ID Q86WV6
OMIM ID 612374
HGNC ID 27962
Aliases TMEM173, STING, MITA, ERIS, MPYS, NET23

Description

STING1 (Stimulator of Interferon Response cGAMP Interactor 1), previously known as TMEM173, encodes STING, a key adaptor protein in the innate immune system. STING is located on the endoplasmic reticulum membrane and acts as a cytosolic DNA sensor. Upon binding cyclic dinucleotides (such as cGAMP produced by cGAS), STING undergoes conformational changes, translocates to the Golgi, and activates TBK1 and IRF3, leading to type I interferon production and pro-inflammatory cytokines. STING1 is critical for defense against viral and bacterial infections, and its dysregulation is linked to autoinflammatory diseases and cancer.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
STING-associated vasculopathy with onset in infancy (SAVI) Gain-of-function mutations (e.g., V155M, N154S) cause constitutive activation of STING, leading to excessive type I interferon signaling and systemic inflammation. ClinVar, OMIM
Aicardi-Goutières syndrome (AGS)-like phenotype Rare STING1 variants may mimic AGS, presenting with interferonopathy and neurological symptoms. ClinVar, OMIM
Lung cancer STING1 expression is often downregulated in tumors, evading immune surveillance; loss of STING function correlates with poor prognosis. COSMIC, PubMed
Colorectal cancer STING pathway activation can promote anti-tumor immunity, but chronic activation may induce immune exhaustion. COSMIC, PubMed
Viral infections (e.g., HSV-1) Loss-of-function variants impair interferon response, increasing susceptibility to viral infections. PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Lung 12.4 Medium
Spleen 10.8 Medium
Blood 8.5 Low
Liver 6.2 Low
Brain 2.1 Not detected
Cell Line Expression
Cell Line nTPM Notes
HeLa 15.3 Cervical cancer cell line; high expression
A549 11.2 Lung carcinoma; moderate expression
THP-1 18.7 Monocytic leukemia; high expression
MCF7 5.4 Breast cancer; low expression
HUVEC 7.8 Endothelial; low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
V155M Missense Germline (SAVI) Gain-of-function; constitutive activation
N154S Missense Germline (SAVI) Gain-of-function; constitutive activation
R284S Missense Somatic (cancer) Loss-of-function; impaired signaling
R71H Missense Somatic (cancer) Loss-of-function; reduced interferon induction
R232H Missense Common polymorphism Altered cGAMP binding; reduced function
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations (e.g., R284S, R71H) impair STING's ability to bind cGAMP or activate downstream signaling, leading to defective interferon production and increased susceptibility to infections and immune evasion in cancer.

Gain of Function (GOF)

Gain-of-function mutations (e.g., V155M, N154S) cause ligand-independent STING activation, resulting in constitutive type I interferon signaling and autoinflammatory disease (SAVI).

Dominant Negative (DN)

Some STING1 variants may act in a dominant-negative manner, interfering with wild-type STING function, though specific examples are less characterized; further research is needed.

Gene Ontology (GO)

• GO:0005737 (cytoplasm) • GO:0005783 (endoplasmic reticulum)
• GO:0005789 (endoplasmic reticulum membrane) • GO:0005829 (cytosol)
• GO:0042802 (identical protein binding) • GO:0046872 (metal ion binding)
• GO:0005515 (protein binding) • GO:0003723 (RNA binding)
• GO:0045087 (innate immune response) • GO:0009615 (response to virus)
• GO:0035458 (cellular response to interferon-beta) • GO:0002753 (cytoplasmic pattern recognition receptor signaling pathway)
• GO:0002224 (toll-like receptor signaling pathway) • GO:0006954 (inflammatory response)
• GO:0006915 (apoptotic process)

Pathways

cGAS-STING signaling pathway
Cytosolic DNA-sensing pathway
Innate Immune System
Type I interferon production
NF-kappaB signaling
Autophagy

Protein Summary

STING (Stimulator of Interferon Genes) is a 42 kDa transmembrane protein with an N-terminal cytoplasmic domain, four transmembrane helices, and a C-terminal domain that binds cyclic dinucleotides. It resides primarily on the endoplasmic reticulum membrane. Upon activation by cGAMP, STING undergoes a conformational change, oligomerizes, and translocates to the Golgi apparatus, where it recruits TBK1 and IRF3, leading to phosphorylation and nuclear translocation of IRF3 to induce type I interferons. STING also activates NF-κB via IKK. Its activity is tightly regulated by post-translational modifications (e.g., ubiquitination, phosphorylation) and interactions with proteins like TRIM32, TRIM56, and AMFR. STING is a promising therapeutic target for cancer immunotherapy and vaccine adjuvants.

Related Products

Product name Cat.No. Species Gene ID
STING1 Knockout HEK293 Cell Line EDJ-KQ15539 Human 340061 Details Get a Quote
STING1 Knockout HeLa Cell Line EDJ-KQ17959 Human 340061 Details Get a Quote
STING1 Knockout A-549 Cell Line EDJ-KQ18181 Human 340061 Details Get a Quote
STING1 Knockout HCT 116 Cell Line EDJ-KQ46382 Human 340061 Details Get a Quote
Sting1 Knockout 4T1 Cell Line EDJ-KZ497 Mouse 72512 Details Get a Quote
STING1 Knockout VeroE6/TMPRSS2 Cell Line EDJ-KZ498 African green monkey 340061 Details Get a Quote
STING1 Knockout THP-1 Cell Line EDJ-KQ78089 Human 27962 Details Get a Quote
Displaying Records 1 To 7 Of 7 Records
Contact Us
*
*
*
*
How did you hear about us: